UnitedHealth Group Incorporated (NYSE:UNH) Receives $455.92 Consensus PT from Analysts

UnitedHealth Group Incorporated (NYSE:UNH) has been given an average recommendation of “Moderate Buy” by the twenty-seven research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation, nineteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $456.56.

Several research analysts have recently commented on UNH shares. DA Davidson set a $512.00 price target on UnitedHealth Group in a research report on Tuesday, July 21st. Piper Sandler set a $477.00 target price on UnitedHealth Group in a report on Thursday, July 16th. HC Wainwright set a $492.00 price target on shares of UnitedHealth Group in a research report on Wednesday, May 27th. KeyCorp lifted their price objective on shares of UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Finally, Truist Financial raised their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.19% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group in the fourth quarter valued at $25,000. Anfield Capital Management LLC increased its holdings in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $27,000. Nalls Sherbakoff Group LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Lifetime Wealth Management P.C. purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $29,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.3%

Shares of UNH stock opened at $393.99 on Monday. The company has a 50-day moving average of $413.28 and a two-hundred day moving average of $360.71. The firm has a market cap of $353.64 billion, a PE ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62. UnitedHealth Group has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the business posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts predict that UnitedHealth Group will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.